Caixin
Caixin Global – Latest China News & Headlines

Home >

BGI Genomics to Invest in Qingdao Medical Park

By Tang Ziyi / Jun 26, 2019 06:08 PM / Business & Tech

Photo: IC Photo

Photo: IC Photo

Chinese genomics giant BGI Genomics will spend 470 million yuan ($68.3 million) on establishing an industrial park in the eastern port city of Qingdao, Shandong province, the company said Tuesday.

The planned medical park will focus on researching and developing tests for conditions including congenital diseases and tumors, according to the statement.

The Qingdao medical park is the latest in a wave of genetics industrial parks that are sweeping China, as the country hopes to dominate the burgeoning industry. The controversial announcement last year that the world’s first genetically altered babies had been born in China drew attention to the southern Chinese city of Shenzhen, where the scientist who claimed to have altered the babies’ DNA — He Jiankui — had worked. Shenzhen is home to two of China’s biggest genetics industrial parks, including one jointly financed by BGI.

Related: Genome Sequencing Giant BGI's Fundraising Flops

A previous version of this story inaccurately described He Jiankui's connection to a BGI-funded park in Shenzhen.

Contact reporter Tang Ziyi (ziyitang@caixin.com)

Share this article
Open WeChat and scan the QR code
Copyright © 2019 Caixin Global Limited. All Rights Reserved.